A comparative analysis of antidepressant and anti-suicidal effects of repeated ketamine infusions in elderly and younger adults with depression

Ketamine induces rapid antidepressant effects via the autophagy-NLRP3 inflammasome pathway

(2022) Dongbin Lyu et al.   PSYCHOPHARMACOLOGY

Adjunctive accelerated repetitive transcranial magnetic stimulation for older patients with depression: A systematic review

(2022) Wei Zheng et al.   Frontiers in Aging Neuroscience

Transient Cognitive Impairment and White Matter Hyperintensities in Severely Depressed Older Patients Treated With Electroconvulsive Therapy

(2021) Margot J. Wagenmakers et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Premedication with dexmedetomidine for prevention of hyperdynamic response after electroconvulsive therapy: a cross-over, randomized controlled trial

(2021) Pattika Subsoontorn et al.   BMC Psychiatry

Age affects temporal response, but not durability, to serial ketamine infusions for treatment refractory depression

(2021) Steven Pennybaker et al.   PSYCHOPHARMACOLOGY

Electroconvulsive Therapy and Age: Effectiveness, Safety and Tolerability in the Treatment of Major Depression among Patients under and over 65 Years of Age

(2021) Monika Dominiak et al.   Pharmaceuticals

Comparison of Long-Term Efficacy and Safety of Esketamine Nasal Spray Plus Oral Antidepressant in Younger Versus Older Patients With Treatment-Resistant Depression: Post-Hoc Analysis of SUSTAIN-2, a Long-Term Open-Label Phase 3 Safety and Efficacy Study

(2021) Rachel Ochs-Ross et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial

(2021) Marijn Lijffijt et al.   NEUROPSYCHOPHARMACOLOGY

Comparative effectiveness of repeated ketamine infusions in treating anhedonia in bipolar and unipolar depression

(2021) Wei Zheng et al.   JOURNAL OF AFFECTIVE DISORDERS

Predictors of response to repeated ketamine infusions in depression with suicidal ideation: An ROC curve analysis

(2020) Yanling Zhou et al.   JOURNAL OF AFFECTIVE DISORDERS

Adjunctive intranasal esketamine for major depressive disorder: A systematic review of randomized double-blind controlled-placebo studies

(2020) Wei Zheng et al.   JOURNAL OF AFFECTIVE DISORDERS

A systematic review of ketamine for the treatment of depression among older adults

(2020) Aarti Gupta et al.   INTERNATIONAL PSYCHOGERIATRICS

Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder

(2019) Wei Zheng et al.   JOURNAL OF PSYCHOPHARMACOLOGY

A preliminary study of anti-suicidal efficacy of repeated ketamine infusions in depression with suicidal ideation

(2019) Yanni Zhan et al.   JOURNAL OF AFFECTIVE DISORDERS

Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3

(2019) Rachel Ochs-Ross et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial

(2018) Michael F. Grunebaum et al.   AMERICAN JOURNAL OF PSYCHIATRY

Prevalence of insomnia symptoms and their associated factors in patients treated in outpatient clinics of four general hospitals in Guangzhou, China

(2018) Wei Zheng et al.   BMC Psychiatry

Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression

(2018) Wei Zheng et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Prevalence of depression: Comparisons of different depression definitions in population-based samples of older adults

(2017) Linnea Sjöberg et al.   JOURNAL OF AFFECTIVE DISORDERS

Antisuicidal Response Following Ketamine Infusion Is Associated With Decreased Nighttime Wakefulness in Major Depressive Disorder and Bipolar Disorder

(2017) Jennifer L. Vande Voort et al.   JOURNAL OF CLINICAL PSYCHIATRY

Quality of life and clinical correlates in older adults living in the community and in nursing homes in Macao

(2017) Kenny C. F. Kuok et al.   Psychogeriatrics

Quality of life and clinical correlates in older adults living in the community and in nursing homes in Macao

(2017) Kenny C. F. Kuok et al.   Psychogeriatrics

Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories

(2016) T. Kishimoto et al.   PSYCHOLOGICAL MEDICINE

Epidemiology and temporal trend of suicide mortality in the elderly in Jiading, Shanghai, 2003–2013: a descriptive, observational study

(2016) Yueqin Shao et al.   BMJ Open

Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study

(2015) Y.-D. Hu et al.   PSYCHOLOGICAL MEDICINE

Safety and efficacy of ketamine infusion in late onset depression, and conversion to treatment response

(2015) Shrikant Srivastava et al.   Indian Journal of Psychiatry

Failed Response to Repeat Intravenous Ketamine Infusions in Geriatric Patients With Major Depressive Disorder

(2014) Sarah M. Szymkowicz et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression

(2013) Paulo R. Shiroma et al.   JOURNAL OF AFFECTIVE DISORDERS

Serial infusions of low-dose ketamine for major depression

(2013) Keith G Rasmussen et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Differences Between Younger and Older Adults in the Structure of Suicidal Intent and Its Correlates

(2010) Marta Miret et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression

(2009) Marije aan het Rot et al.   BIOLOGICAL PSYCHIATRY